Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 1, 2009, Pages

  Stadlbauer, V ^a,b   Mookerjee, R P ^a   Wright, G A K ^a   Davies, N A ^a   Jurgens G ^c   Hallstrom S ^c   Jalan, R ^a,d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Institute of Hepatology   (United Kingdom)

Author keywords

Acute on chronic liver failure; Alcoholic liver disease; Chemokines; Endotoxin; Immune function

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; HUMAN ALBUMIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENERGY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST;

ADENOSINE TRIPHOSPHATE; CASE-CONTROL STUDIES; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RESPIRATORY BURST; SERUM ALBUMIN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 58249104043     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90512.2008     Document Type: Article

References (35)

1. Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 13: 2487-2502, 2006.
2. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474, 1999.
3. Bugajski P, Kalawski R, Balinski M, Wysocki H, Olszewski R, Szczepanik A, Siminiak T. Plasma-mediated stimulation of neutrophil superoxide anion production during coronary artery bypass grafting: role of endothelin-1. Thorac Cardiovasc Surg 47: 144-147, 1999.
4. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 162: 2341-2346, 1999.
5. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14, 1999.
6. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35: 140-148, 2002.
7. Frances R, Zapater P, Gonzalez-Navajas JM, Munoz C, Cano R, Moreu R, Pascual S, Bellot P, Perez-Mateo M, Such J. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 47: 978 -985, 2008.
8. Furst W, Hallstrom S. Simultaneous determination of myocardial nucle-otides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatography. J Chromatogr 578: 39-44, 1992.
9. Hallstrom S, Gasser H, Neumayer C, Fugl A, Nanobashvili J, Jakubowski A, Huk I, Schlag G, Malinski T. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 105: 3032-3038, 2002.
10. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, Roos D, Griese M. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13: 1423-1430, 2007.
11. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669, 2003.
12. Jalan R, Kapoor D. Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci (Lond) 106: 467-474, 2004.
13. Jurgens G, Muller M, Garidel P, Koch MH, Nakakubo H, Blume A, Brandenburg K. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J Endotoxin Res 8: 115-126, 2002.
14. Khandaker MH, Xu L, Rahimpour R, Mitchell G, DeVries ME, Pickering JG, Singhal SK, Feldman RD, Kelvin DJ. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J Immunol 161: 1930-1938, 1998.
15. Kono H, Rusyn I, Uesugi T, Yamashina S, Connor HD, Dikalova A, Mason RP, Thurman RG. Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol 280: G1005-G1012, 2001.
16. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM, Thurman RG. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106: 867-872, 2000.
17. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, Jalan R. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46: 831-840, 2007.
18. Murphy PM. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34: 311-318, 1997.
19. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jimenez W, Arroyo V, Rodes J. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36: 941-948, 2002.
20. Parker LC, Whyte MK, Dower SK, Sabroe I. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 77: 886-892, 2005.
21. Pascual C, Bredle D, Karzai W, Meier-Hellmann A, Oberhoffer M, Reinhart K. Effect of plasma and LPS on respiratory burst of neutrophils in septic patients. Intensive Care Med 24: 1181-1186, 1998.
22. Pelzmann B, Hallstrom S, Schaffer P, Lang P, Nadlinger K, Birkmayer GD, Vrecko K, Reibnegger G, Koidl B. NADH supplementation decreases pinacidil-primed I K ATP in ventricular cardiomyocytes by increasing intracellular ATP. Br J Pharmacol 139: 749-754, 2003.
23. Piccolo MT, Sannomiya P. Inhibition of neutrophil chemotaxis by plasma of burned patients: effect of blood transfusion practice. Burns 21: 569 -574, 1995.
24. Rajkovic IA, Williams R. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci (Lond) 68: 247-253, 1985.
25. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 39: 841-856, 2004.
26. Sabroe I, Dower SK, Whyte MK. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41, Suppl 7: S421-S426, 2005.
27. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168: 4701-4710, 2002.
28. Sabroe I, Jones EC, Whyte MK, Dower SK. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology 115: 90 -98, 2005.
29. Siminiak T, Egdell RM, O'Gorman DJ, Dye JF, Sheridan DJ. Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor. Clin Sci (Lond) 89: 171-176, 1995.
30. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403-409, 1999.
31. Stadlbauer V, Davies NA, Sen S, Jalan R. Artificial liver support systems in the management of complications of cirrhosis. Semin Liver Dis 28: 96-109, 2008.
32. Stanley AJ, MacGregor IR, Dillon JF, Bouchier IA, Hayes PC. Neutrophil activation in chronic liver disease. Eur J Gastroenterol Hepa-tol 8: 135-138, 1996.
33. Sturk A, Joop K, ten Cate JW, Thomas LL. Optimalization of a chromogenic assay for endotoxin in blood. Prog Clin Biol Res 189: 117-137, 1985.
34. Taieb J, Mathurin P, Elbim C, Cluzel P, Arce-Vicioso M, Bernard B, Opolon P, Gougerot-Pocidalo MA, Poynard T, Chollet-Martin S. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. J Hepatol 32: 579 -586, 2000.
35. Van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76: 2520-2526, 1990.